Apella Raises $80M Series B to Optimize Hospital Operating Rooms with AI
The funding enables Apella to accelerate development and deployment of its AI platform for hospitals. Its technology aims to optimize operating room scheduling and utilization, enhancing patient access and improving clinician work conditions.
Funding and Purpose
- $80 million Series B round raised.
- Focus on AI platform to optimize hospital operating rooms (ORs).
Technology and Impact
- Boosts surgical volumes without adding new staff or facilities.
- Aims to reduce clinician burnout by improving workflow.
- Enhances patient access to surgeries through better OR management.
Market Context
- Healthcare systems seek efficiency gains amid rising demand and staff shortages.
- AI solutions like Apella’s address critical bottlenecks in surgical care delivery.
Join the BioIntel newsletter
Get curated biotech intelligence across AI, industry, innovation, investment, medtech, and policy—delivered to your inbox.